Skip to main content

Intellipharmaceutics International Inc. (IPCIF)

OTCMKTS: IPCIF · Delayed Price · USD
0.1402 0.0102 (7.85%)
Sep 20, 2021 3:54 PM EDT - Market closed
Market Cap4.64M
Revenue (ttm)1.40M
Net Income (ttm)-3.39M
Shares Out33.09M
EPS (ttm)-0.10
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,113
Open0.1313
Previous Close0.1300
Day's Range0.1313 - 0.1402
52-Week Range0.0588 - 0.4800
Beta1.09
Analystsn/a
Price Targetn/a
Est. Earnings DateOct 14, 2021

About IPCIF

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for...

IndustryPharmaceuticals
Founded1998
CEOIsa Odidi
Employees13
Stock ExchangeOTCMKTS
Ticker SymbolIPCIF
Full Company Profile

Financial Performance

In 2020, IPCIF's revenue was $1.40 million, a decrease of -59.73% compared to the previous year's $3.48 million. Losses were -$3.39 million, -58.06% less than in 2019.

Financial Statements

News

Kim Spencer McPhee Barristers, P.C. Publishes This Notice of Certification and Notice of Hearing for Settlement Appro...

TORONTO--(BUSINESS WIRE)--Kim Spencer McPhee Barristers, P.C. today announces a proposed securities class action settlement regarding Intellipharmaceutics International Inc. (“IPCI”). In 2019, a propose...

2 months ago - Business Wire

Intellipharmaceutics Announces Closing of CAD$3.85 Million Non-Brokered Private Placement

TORONTO, ON / ACCESSWIRE / April 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the r...

4 months ago - Accesswire

Intellipharmaceutics Announces First Quarter 2021 Results

TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the resear...

5 months ago - Accesswire

Intellipharmaceutics Announces Fiscal Year 2020 Results

TORONTO, ON / ACCESSWIRE / March 1, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the re...

6 months ago - Accesswire

Intellipharmaceutics Reports Director Election Results

TORONTO, ON / ACCESSWIRE / December 23, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the re...

8 months ago - Accesswire